Ken Griffin BIOLINE RX LIMITED Transaction History

Citadel Advisors LLC

  • $618 Billion
  • Q3 2025
Number of Shares
10,020
Previous 43,500 76.97%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
N/A
-4,934 Reduced 32.99%
10,020 $0
Q2 2025

Aug 14, 2025
BUY
N/A
14,954 New
14,954 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email